




Mounjaro 12.5mg KwikPen Solution For Injection 2.4ml Pre-Filled Pens (Eli Lilly and Company Ltd) (FREE NEEDLES SUPPLIED)


£ 0.00
Login to your account to view price and product availability.
*** Your prescriber MUST be CQC registered for this product to be prescribed, please ask them to include their CQC location ID and postcode on the prescriptions notes. Any orders from prescribers without CQC registration will be rejected (Does not apply to Pharmacist prescribers) *** FOR PRESCRIBERS PLEASE INPUT THE BMI OF THE PATIENT SOMEWHERE ON THE PRESCRIPTION, WITHOUT THIS THE ORDER WILL BE DELAYED AS WE WILL HAVE TO CONTACT YOU FOR THIS INFORMATION. Mounjaro (tirzepatide) 12.5mg injection, is a prescription medicine for adults with type 2 diabetes used along with diet and exercise to improve blood sugar (glucose). It is not known if Mounjaro can be used in people who have had insulinotropic Mounjaro is not for use in people with type 1 diabetes. It is not known if Mounjaro is safe and effective for use in children under 18 years of age.
Compare insurance quotes from trusted partners.
5.0 (4,005)
238 products
6,763 sold


Results from Mounjaro 12.5mg KwikPen can typically be observed within a few weeks of starting treatment, with optimal effects often seen after several months. Individual responses vary based on factors such as adherence to prescribed dosage and lifestyle changes. For best outcomes, consult your healthcare professional regarding a tailored approach to using Mounjaro in your treatment plan.
The results from Mounjaro 12.5mg KwikPen Solution for Injection typically last as long as the medication is actively used, with most patients experiencing sustained effects when adhering to their prescribed regimen. Individual results may vary based on factors such as diet, exercise, and overall health. For optimal outcomes, it’s essential to maintain regular follow-up consultations with your healthcare provider.
Mounjaro 12.5mg KwikPen Solution for Injection is not suitable for everyone. It is primarily indicated for adults with type 2 diabetes and should be used under medical supervision. Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 are advised against its use. Always consult a healthcare professional to determine if Mounjaro is appropriate for your specific health needs.
Mounjaro 12.5mg KwikPen may cause side effects, including nausea, diarrhoea, vomiting, and decreased appetite. Some individuals might experience injection site reactions or headaches. It's important to consult a healthcare professional if you encounter severe or persistent symptoms. As with any medication, monitor your health closely while using Mounjaro for optimal results in managing weight and related conditions.
Yes, Mounjaro 12.5mg KwikPen can be combined with other treatments, but it’s essential to consult your healthcare provider first. They will assess your individual health needs and any potential interactions with other medications or therapies. Combining Mounjaro with lifestyle changes and other supportive treatments may enhance weight management results. Always follow professional guidance for optimal safety and effectiveness.
After administering Mounjaro 12.5mg via the KwikPen, apply gentle pressure to the injection site with a clean cotton ball or gauze. Avoid rubbing the area to minimise discomfort and bruising. Keep the site clean and dry, monitoring for any signs of infection, such as redness or swelling. Stay hydrated and follow your healthcare provider's guidance on diet and activity for optimal results in managing weight and blood sugar levels.
7 day returns accepted for unopened items, no opened items will be refunded.
Buyer to cover cost for return and/or replacement item.
Incorrect goods must be returned for replacement at a cost to seller.
Dpd courier delays are not the responsibility of Aesthipharma. No refunds offered.
See company policy
© 2026 Faces Consent. All rights reserved.